Product Details for ANDA 040547
METHIMAZOLE (METHIMAZOLE)
5MG
Marketing Status: Prescription
10MG
Marketing Status: Prescription
20MG
Marketing Status: Discontinued
5MG
Marketing Status: Prescription
Active Ingredient: METHIMAZOLE
Proprietary Name: METHIMAZOLE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A040547
Product Number: 001
Approval Date: Feb 18, 2005
Applicant Holder Full Name: QINGDAO BAHEAL PHARMACEUTICAL CO LTD
Marketing Status: Prescription
Patent and Exclusivity Information
METHIMAZOLE (METHIMAZOLE)
Proprietary Name: METHIMAZOLE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A040547
Product Number: 001
Approval Date: Feb 18, 2005
Applicant Holder Full Name: QINGDAO BAHEAL PHARMACEUTICAL CO LTD
Marketing Status: Prescription
Patent and Exclusivity Information
10MG
Marketing Status: Prescription
Active Ingredient: METHIMAZOLE
Proprietary Name: METHIMAZOLE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A040547
Product Number: 002
Approval Date: Feb 18, 2005
Applicant Holder Full Name: QINGDAO BAHEAL PHARMACEUTICAL CO LTD
Marketing Status: Prescription
Patent and Exclusivity Information
METHIMAZOLE (METHIMAZOLE)
Proprietary Name: METHIMAZOLE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A040547
Product Number: 002
Approval Date: Feb 18, 2005
Applicant Holder Full Name: QINGDAO BAHEAL PHARMACEUTICAL CO LTD
Marketing Status: Prescription
Patent and Exclusivity Information
20MG
Marketing Status: Discontinued
Active Ingredient: METHIMAZOLE
Proprietary Name: METHIMAZOLE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 20MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A040547
Product Number: 004
Approval Date: Feb 18, 2005
Applicant Holder Full Name: QINGDAO BAHEAL PHARMACEUTICAL CO LTD
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: METHIMAZOLE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 20MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A040547
Product Number: 004
Approval Date: Feb 18, 2005
Applicant Holder Full Name: QINGDAO BAHEAL PHARMACEUTICAL CO LTD
Marketing Status: Discontinued
Patent and Exclusivity Information